Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inko Nimmrich

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Personalized Medicine|May 24, 2018
DNA methylation markers - an opportunity to further individualize therapy in breast cancer?Sabine Maier, Ralf Lesche, Inko Nimmrich, et al.
The Biochemical Journal|August 3, 2002
Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activationSlava Chtarbova, Inko Nimmrich, Silke Erdmann, et al.
Annals of Hematology|November 13, 2004
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysisChristian Scholz, Inko Nimmrich, Matthias Burger, et al.
Journal of Cellular Biochemistry|December 4, 2002
Oligonucleotide-based microarray for DNA methylation analysis: principles and applicationsHuidong Shi, Sabine Maier, Inko Nimmrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomasHongyu Yang, Chuan-Mu Chen, Pearlly Yan, et al.
American Journal of Clinical Pathology|September 30, 2005
Differential DNA methylation of gene promoters in small B-cell lymphomasJuyuan Guo, Matthias Burger, Inko Nimmrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patientsNadia Harbeck, Inko Nimmrich, Arndt Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2007
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology groupSabine Maier, Inko Nimmrich, Thomas Koenig, et al.
Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Cancer Research|May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancerJohn W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Personalized Medicine|May 24, 2018
DNA methylation markers - an opportunity to further individualize therapy in breast cancer?Sabine Maier, Ralf Lesche, Inko Nimmrich, et al.
The Biochemical Journal|August 3, 2002
Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activationSlava Chtarbova, Inko Nimmrich, Silke Erdmann, et al.
Annals of Hematology|November 13, 2004
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysisChristian Scholz, Inko Nimmrich, Matthias Burger, et al.
Journal of Cellular Biochemistry|December 4, 2002
Oligonucleotide-based microarray for DNA methylation analysis: principles and applicationsHuidong Shi, Sabine Maier, Inko Nimmrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomasHongyu Yang, Chuan-Mu Chen, Pearlly Yan, et al.
American Journal of Clinical Pathology|September 30, 2005
Differential DNA methylation of gene promoters in small B-cell lymphomasJuyuan Guo, Matthias Burger, Inko Nimmrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patientsNadia Harbeck, Inko Nimmrich, Arndt Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2007
DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology groupSabine Maier, Inko Nimmrich, Thomas Koenig, et al.
Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Cancer Research|May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancerJohn W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Pageof 1